June E. Nylen Cancer Center

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Brian G.M. Durie, Antje Hoering, Muneer H. Abidi et al. · The Lancet · 2016 · 868 citations · Full text

Hematological Malignancy, Dexamethasone Versus Lenalidomide, Oncology +9

Rey complex figure test under four different administration procedures

John E. Meyers, Kelly R. Meyers · The Clinical Neuropsychologist · 1995 · 250 citations

Different Administration Procedures, Cognitive Science, Raw Scores +12

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

Brian G.M. Durie, Antje Hoering, Rachael Sexton et al. · Blood Cancer Journal · 2020 · 246 citations · Full text

Cytokinin Induction of Root Nodule Primordia in <i>Lotus japonicus</i> Is Regulated by a Mechanism Operating in the Root Cortex

Anne B. Heckmann, Niels Sandal, Anita S. Bek et al. · Molecular Plant-Microbe Interactions · 2011 · 181 citations · Full text

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

Lisa A. Kottschade, Jeff A. Sloan, Miroslaw Mazurczak et al. · Supportive Care in Cancer · 2010 · 172 citations · Full text

Vitamin E, Neuro-oncology, Medicine +7